The serotonin syndrome

Emerg Med Clin North Am. 1997 Aug;15(3):665-75. doi: 10.1016/s0733-8627(05)70324-2.

Abstract

The serotonin syndrome is characterized by mental status changes and a variety of autonomic and neuromuscular manifestations. Its duration is usually brief, resolving within hours provided that the inciting agent has been discontinued. In most cases, two or more types of medications known to increase the activity of serotonin at the 5-HT1A receptor are required to produce it, and it frequently begins soon after the initiation of a new treatment regimen. Treatment is largely supportive although limited clinical experience warrants the cautious use of specified agents. Although its overall incidence is unknown, it is probably low, and an appropriate level of suspicion coupled with an adequate knowledge of the patient's drug history remains the mainstay of diagnosis and treatment.

Publication types

  • Review

MeSH terms

  • Diagnosis, Differential
  • Drug Interactions
  • Humans
  • Mental Disorders / chemically induced*
  • Mental Disorders / diagnosis
  • Mental Disorders / physiopathology
  • Mental Disorders / therapy
  • Movement Disorders / diagnosis
  • Movement Disorders / etiology*
  • Movement Disorders / physiopathology
  • Movement Disorders / therapy
  • Serotonin / metabolism*
  • Serotonin Agents / adverse effects*
  • Serotonin Agents / metabolism
  • Syndrome

Substances

  • Serotonin Agents
  • Serotonin